Cambridge Innovation Capital (CIC) has launched a £100M Opportunity Fund aiming to enhance investments in advanced deep tech and life sciences companies during their growth stage. With support from Aviva Investors and British Patient Capital, the fund addresses a significant funding gap in the UK, which often sees promising businesses seek foreign investment. CIC’s Managing Partner Andrew Williamson emphasized the importance of this fund in retaining UK companies. The fund can invest up to £20M per company and has already made investments in notable firms like Pragmatic Semiconductor and Riverlane.
The fund aims to invest in advanced deep tech and life sciences companies at the growth stage, securing pivotal UK businesses as they scale.
Andrew Williamson stated that the new fund will support UK ecosystem scale-ups at a crucial growth moment, addressing the UK's funding gap.
The Opportunity Fund intends to bridge the UK’s scale-up funding gap, reinforcing Cambridge's status in Europe's Silicon Valley transformation.
Investments have already been made in Pragmatic Semiconductor and Riverlane, showcasing CIC's commitment to supporting homegrown tech businesses.
Collection
[
|
...
]